Aktie

DECIBEL THERAP. DL -,001

WKN
A2QNAQ
Ticker
DBTX
ISIN
US24343R1068

Unternehmens­daten

Stammdaten zu DECIBEL THERAP. DL -,001

WKN
A2QNAQ
ISIN
US24343R1068
Home-Symbol
DBTX
Symbol
Branche
Sektor
Unternehmen
Land

Marktdaten

Marktkapitalisierung
Anzahl Aktien
Streubesitz

Mitglieder & Anteilseigner

Anteilseigner

OrbiMed Advisors Private EquityThird Rock Ventures LLCRegeneron Pharmaceuticals, Inc.BlackRock Advisors LLCAlphabet, Inc.Samsara Biocapital LLCThe Vanguard Group, Inc.Bessemer Investment Management LLCHarvard Management Co., Inc.Foresite Capital Management LLCNewtyn Management LLCUBS O'Connor LLCMillennium Management LLCBronte Capital Management Pty Ltd.Point72 Asset Management LPBridgeway Capital Management LLCGeode Capital Management LLCJPMorgan Investment Management, Inc.Neuberger Berman Investment Advisers LLCAcuitas Investments LLC
  • OrbiMed Advisors Private Equity (19,68 %)
  • Third Rock Ventures LLC (12,50 %)
  • Regeneron Pharmaceuticals, Inc. (8,35 %)
  • BlackRock Advisors LLC (6,92 %)
  • Alphabet, Inc. (6,51 %)
  • Samsara Biocapital LLC (3,19 %)
  • The Vanguard Group, Inc. (2,55 %)
  • Bessemer Investment Management LLC (1,97 %)
  • Harvard Management Co., Inc. (1,30 %)
  • Foresite Capital Management LLC (1,18 %)
  • Newtyn Management LLC (0,80 %)
  • UBS O'Connor LLC (0,79 %)
  • Millennium Management LLC (0,63 %)
  • Bronte Capital Management Pty Ltd. (0,62 %)
  • Point72 Asset Management LP (0,53 %)
  • Bridgeway Capital Management LLC (0,47 %)
  • Geode Capital Management LLC (0,46 %)
  • JPMorgan Investment Management, Inc. (0,41 %)
  • Neuberger Berman Investment Advisers LLC (0,23 %)
  • Acuitas Investments LLC (0,17 %)

Kontakt